{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:28:06Z","timestamp":1785583686752,"version":"3.56.0"},"reference-count":24,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This case presents an unusual presentation of severe hypocalcemia, hypomagnesemia, and hypokalemia that suddenly developed in a patient with a prior 15-year history of proton pump inhibitor (PPI) use with no prior complications. The patient developed acute onset of persistent tingling and numbness in her fingertips followed by acute confusion and perioral tingling. Upon hospitalization, she was found to have severe hypocalcemia, hypomagnesemia, and hypokalemia and required IV electrolyte repletion. This episode recurred, prompting the discontinuation of her PPI therapy. This unusual timing prompted an extensive workup to exclude alternative etiologies of hypocalcemia. Ultimately, PPI-induced hypomagnesemia was identified as the primary driver of the patient's electrolyte abnormalities. This case serves dual teaching points. First, it underscores the importance of recognizing that refractory hypocalcemia and hypokalemia can often be linked to untreated hypomagnesemia so that timely diagnosis, effective management, and minimization of hospitalizations can be ensured. Second, this case highlights the unusual timing of symptomatic hypomagnesemia and subsequent hypocalcemia and hypokalemia despite years of prior PPI usage without prior known complications.<\/jats:p>","DOI":"10.1210\/jcemcr\/luaf125","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T05:17:41Z","timestamp":1749446261000},"source":"Crossref","is-referenced-by-count":2,"title":["Late-onset Complications in a Chronic Proton Pump Inhibitor User: Electrolyte Abnormalities and a Diagnostic Approach"],"prefix":"10.1210","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5790-4894","authenticated-orcid":false,"given":"Danielle H","family":"Tran","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Washington , Seattle, WA 98195-6421 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R","family":"Fredrick","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington Medical Center , Seattle, WA 98195-6421 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika R","family":"Narla","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington Medical Center , Seattle, WA 98195-6421 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"issue":"11","key":"2025060901173819900_luaf125-B1","doi-asserted-by":"crossref","first-page":"e112558","DOI":"10.1371\/journal.pone.0112558","article-title":"The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis","volume":"9","author":"Park","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"2025060901173819900_luaf125-B2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2012.05128.x","article-title":"Review article: current treatment options and management of functional dyspepsia","volume":"36","author":"Lacy","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"2025060901173819900_luaf125-B3","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2008.08.045","article-title":"American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"issue":"9","key":"2025060901173819900_luaf125-B4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archinternmed.2010.94","article-title":"Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative","volume":"170","author":"Gray","year":"2010","journal-title":"Arch Intern Med"},{"issue":"20","key":"2025060901173819900_luaf125-B5","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.2009.722","article-title":"Acid-suppressive medication use and the risk for hospital-acquired pneumonia","volume":"301","author":"Herzig","year":"2009","journal-title":"JAMA"},{"issue":"9","key":"2025060901173819900_luaf125-B6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archinternmed.2010.89","article-title":"Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection","volume":"170","author":"Howell","year":"2010","journal-title":"Arch Intern Med"},{"issue":"4","key":"2025060901173819900_luaf125-B7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2036.2007.03407.x","article-title":"Systematic review: proton pump inhibitor-associated acute interstitial nephritis","volume":"26","author":"Sierra","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"2025060901173819900_luaf125-B8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4068\/cmj.2023.59.2.115","article-title":"Adverse effects associated with long-term use of proton pump inhibitors","volume":"59","author":"Maideen","year":"2023","journal-title":"Chonnam Med J"},{"issue":"17","key":"2025060901173819900_luaf125-B9","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMc066308","article-title":"Proton-pump inhibitors and hypomagnesemic hypoparathyroidism","volume":"355","author":"Epstein","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"2025060901173819900_luaf125-B10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2265.2008.03194.x","article-title":"Severe hypomagnesaemia in long-term users of proton-pump inhibitors","volume":"69","author":"Cundy","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2025060901173819900_luaf125-B11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-151-10-200911170-00016","article-title":"Hypomagnesemia induced by several proton-pump inhibitors [published correction appears in ann intern med. 2010;152(4):268]","volume":"151","author":"Broeren","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"2025060901173819900_luaf125-B12","first-page":"169","article-title":"Hypomagnesaemia due to use of proton pump inhibitors\u2013a review","volume":"67","author":"Kuipers","year":"2009","journal-title":"Neth J Med"},{"issue":"6","key":"2025060901173819900_luaf125-B13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/qjmed\/hcq021","article-title":"Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series","volume":"103","author":"Mackay","year":"2010","journal-title":"QJM"},{"issue":"1","key":"2025060901173819900_luaf125-B14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1053\/j.ajkd.2010.03.013","article-title":"Severe hypomagnesemia during long-term treatment with a proton pump inhibitor","volume":"56","author":"Regolisti","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"44","key":"2025060901173819900_luaf125-B15","doi-asserted-by":"crossref","first-page":"e17788","DOI":"10.1097\/MD.0000000000017788","article-title":"Proton pump inhibitors and hypomagnesemia: a meta-analysis of observational studies","volume":"98","author":"Srinutta","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2025060901173819900_luaf125-B16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5527\/wjn.v5.i2.152","article-title":"Proton-pump inhibitor-induced hypomagnesemia: current research and proposed mechanisms","volume":"5","author":"William","year":"2016","journal-title":"World J Nephrol"},{"issue":"3","key":"2025060901173819900_luaf125-B17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/FPC.0000000000000259","article-title":"Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study","volume":"27","author":"Hess","year":"2017","journal-title":"Pharmacogenet Genomics"},{"issue":"6","key":"2025060901173819900_luaf125-B18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00774-009-0119-x","article-title":"A review of drug-induced hypocalcemia","volume":"27","author":"Liamis","year":"2009","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"2025060901173819900_luaf125-B19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4158\/EP10241.CR","article-title":"Proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism","volume":"17","author":"Milman","year":"2011","journal-title":"Endocr Pract"},{"key":"2025060901173819900_luaf125-B20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/9781119266594.ch85","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Schafer","year":"2018"},{"issue":"40","key":"2025060901173819900_luaf125-B21","doi-asserted-by":"crossref","first-page":"e39729","DOI":"10.1097\/MD.0000000000039729","article-title":"Proton pump inhibitor-induced hypomagnesemia, a rare cause of reversible delirium: a case report with literature review","volume":"103","author":"Zhao","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"2025060901173819900_luaf125-B22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2036.2012.05201.x","article-title":"Systematic review: hypomagnesaemia induced by proton pump inhibition [published correction appears in Aliment Pharmacol Ther. 2012;36(11-12):1109]","volume":"36","author":"Hess","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2025060901173819900_luaf125-B23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2009.11.019","article-title":"A case series of proton pump inhibitor-induced hypomagnesemia","volume":"56","author":"Hoorn","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2025060901173819900_luaf125-B24","first-page":"56","article-title":"Magnesium: the forgotten electrolyte-A review on hypomagnesemia","volume":"7","author":"Ahmed","year":"2019","journal-title":"Med Sci (Basel)"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/7\/luaf125\/63452147\/luaf125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/7\/luaf125\/63452147\/luaf125.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T05:17:45Z","timestamp":1749446265000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luaf125\/8158456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,5,15]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luaf125","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,5,15]]},"article-number":"luaf125"}}